MedPath

ongterm Effects of Intraarticular Hyaluronan vs Corticosteroid in Osteoarthritis of the Hip: A Randomized Controlled Trail

Phase 4
Withdrawn
Conditions
arthritis of the hip
coxarthritis
10023213
Registration Number
NL-OMON34660
Lead Sponsor
Medisch Centrum Leeuwarden
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

above 18 years-old
symptomatic coxarthrosis
signed informed consent

Exclusion Criteria

bad health
ipsilateral gonarthritis
clinical significant neurovascular disease
former surgical procedures of the hip
osteonecrosis, osteomyelitis of the hip
Contraindications to components of Fermatron, Depomedrol or lidocaine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary purpose of the study is to determine the difference in pain<br /><br>reduction and functional recovery between the researchgroups.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1 and 2 years after randomization, an assessment will be carried out in which<br /><br>the percentage of patients in each group that recieved a THP is calculated.<br /><br>In addition, radiological progression during outpatient visits evaluated by<br /><br>X-ray (every half year) will be assessed.<br /><br>A possible effect of hyaluronic acid in negafief recent exacerbation of<br /><br>arthritis is analyzed.</p><br>
© Copyright 2025. All Rights Reserved by MedPath